Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. Colon cancer is a leading cause of cancer-related deaths.

Colon cancer used to feel like a worry for later-something to think about decades down the road. Not anymore. An estimated ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. This voice experience is generated by AI. Learn more. This ...

Tens of millions of middle-aged and older Americans haven't gotten their recommended checks for early signs of potential colon cancer, either through the "gold standard" of colonoscopy or a ...

Colorectal cancer was once considered primarily a disease of aging. But rates are now on the rise among younger adults. Since 2011, colon cancer rates among people younger than 50 have increased by ...

We know that a colonoscopy is the most effective tool for the early detection and prevention of colon cancer. But anyone who has ever had a colonoscopy also knows that it's not necessarily something ...

A host of companies are competing to bring cancer-detecting blood tests to market.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer screening (CRC) is now covered for eligible UnitedHealth Group ...

New Colon Cancer Screening Guidelines Add Blood And At-Home Tests By Dennis Thompson HealthDay ReporterTHURSDAY, May 28, 2026 (HealthDay News) — Blood tests taken in a doctor’s office now can be used ...